BSX

BSX

USD

Boston Scientific Corporation Common Stock

$98.840-0.140 (-0.141%)

Preço em tempo real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$98.980

Máximo

$99.310

Mínimo

$98.250

Volume

4.81M

Fundamentos da empresa

Capitalização de mercado

146.5B

Setor

Dispositivos médicos

País

United States

Estatísticas de negociação

Volume médio

8.69M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $84.13Atual $98.840Máximo $109.5

Notícias relacionadas

Analyst Upgrades

Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130

Truist Securities analyst Richard Newitter maintains Boston Scientific with a Buy and raises the price target from $129 to $130.

Ver mais
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific with a Overweight and raises the price target from $124 to $125.

Ver mais
Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125
Analyst Upgrades

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific with a Overweight and raises the price target from $125 to $130.

Ver mais
Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target

BTIG analyst Marie Thibault reiterates Boston Scientific with a Buy and maintains $132 price target.

Ver mais
BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target
Analyst Upgrades

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.

Ver mais
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
PR Newswire

Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific with a Outperform and lowers the price target from $115 to $110.

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.